AstraZeneca Plc (AZN) agreed to pay $2.5 million to settle Idaho’s claims related to the reported average wholesale prices paid for drugs by the state’s Medicaid program.
The settlement is intended to reimburse taxpayers for excessive prices that the state paid for prescription drugs as a result of inflated average wholesale price reporting, Idaho Attorney General Lawrence Wasden said today in a statement. AstraZeneca denied any wrongdoing.
“AstraZeneca has competed responsibly with respect to pricing and marketing of our medicines, and we firmly believe that we have acted at all times in accordance with the law, Laura Woodin, an AstraZeneca spokeswoman, said today in an e- mailed statement. “This agreement was the appropriate way to resolve this matter quickly and allow the company to focus on our core mission to deliver meaningful medicines to patients.”
Sunday, August 14, 2011
AstraZeneca to Settle Idaho Medicaid Drug-Price Claims for $2.5 Million - Bloomberg
via bloomberg.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment